Emkay Global reiterates BUY with a ₹700 target by June 2025, citing strong execution and robust growth. DART maintains an “Accumulate” rating, noting steady revenue and margin gains. Read More | Source: The Hindu Business Line…
View More Brokerage views on Dabur: Emkay Global and DART insightsCategory: Markets
Stock Market Today: Sensex, Nifty likely to open flat despite record highs
Valuation concerns persist, though institutional participants are holding their positions amidst anticipation for the upcoming Budget and Q1 results of India Inc Read More | Source: The Hindu Business Line…
View More Stock Market Today: Sensex, Nifty likely to open flat despite record highsStocks that will see action today: July 8, 2024
Buzzing stocks: LIC, JM Financial, Infosys, Apollo Hospitals, Bandhan Bank, GMR Power, Coffee Day, PNB, HG Infra, Zaggle, Delhivery, Union Bank, BoB, UGRO Capital, Indsil Hydro, Welspun Corp, Quick Heal, Signature Global, HEG, Genesys Intel, Fermenta Bio, EFC Read More | Source: The Hindu Business Line…
View More Stocks that will see action today: July 8, 2024Mcap: 8 of top-10 most-valued firms jumps ₹1.83 lakh cr; TCS, Infosys biggest gainers
Reliance Industries remained the most valued firm followed by TCS, HDFC Bank, ICICI Bank, Bharti Airtel, SBI, Infosys, LIC, Hindustan Unilever, and ITC. Read More | Source: The Hindu Business Line…
View More Mcap: 8 of top-10 most-valued firms jumps ₹1.83 lakh cr; TCS, Infosys biggest gainersEquity markets to take cue from global trends this week: Analysts
Last week, the BSE benchmark jumped 963.87 points or 1.21 per cent, and Nifty gained 313.25 points or 1.30 per cent. Read More | Source: The Hindu Business Line…
View More Equity markets to take cue from global trends this week: AnalystsIndian equities attract nearly $1 billion FPI Inflows in early July 2024
Experts say FPIs can’t ignore India amid strong economic and earnings growth Read More | Source: The Hindu Business Line…
View More Indian equities attract nearly $1 billion FPI Inflows in early July 2024F&O Query: Should you buy or sell stock derivatives?
Traders can buy TCS call options; stay out of Coforge futures Read More | Source: The Hindu Business Line…
View More F&O Query: Should you buy or sell stock derivatives?F&O Strategy: Long straddle on Fin Nifty
Buy the July expiry 23,500-strike call and put simultaneously Read More | Source: The Hindu Business Line…
View More F&O Strategy: Long straddle on Fin NiftyF&O Tracker: Upward trajectory remains steady
Futures on both Nifty 50 and Bank Nifty looks set to advance further Read More | Source: The Hindu Business Line…
View More F&O Tracker: Upward trajectory remains steadyShort Take: Mphasis F&O contracts adjustment
Mphasis’ dividend announcement will result in its stock price and all derivatives contracts on the stock getting adjusted appropriately on the record date — July 10 Read More | Source: The Hindu Business Line…
View More Short Take: Mphasis F&O contracts adjustmentNTPC, Adani Green, JSW Steel, Tata Steel, Ambuja Cement, Ultratech et al: How their capex plans are driving India’s core sectors
The building blocks have sustained growth along with improved productivity Read More | Source: The Hindu Business Line…
View More NTPC, Adani Green, JSW Steel, Tata Steel, Ambuja Cement, Ultratech et al: How their capex plans are driving India’s core sectorsTech Query: What is the outlook for Rail Vikas Nigam Ltd (RVNL), Union Bank of India, Jain Irrigation Systems?
We zoom in on the prospects of Rail Vikas Nigam Ltd (RVNL), as also the prospects of two other stocks — Union Bank of India, Jain Irrigation Systems Read More | Source: The Hindu Business Line…
View More Tech Query: What is the outlook for Rail Vikas Nigam Ltd (RVNL), Union Bank of India, Jain Irrigation Systems?Nephro Care makes 100% gain at NSE-SME listing
Stock closes at ₹179.5 against IPO price of ₹90 Read More | Source: The Hindu Business Line…
View More Nephro Care makes 100% gain at NSE-SME listingIndia at cusp of major economic transformation: Marcellus
Smartphones, Active Pharmaceutical Ingredients, medical devices to contribute $300 billion to the economy Read More | Source: The Hindu Business Line…
View More India at cusp of major economic transformation: MarcellusEmcure Pharma and Bansal Wire IPOs witness exceptional demand
Emcure Pharma’s IPO, priced between ₹960-1008 per share, and Bansal Wire’s IPO, priced at ₹243-256 per share, collectively raised ₹2,697.03 crore with oversubscriptions of 67.87 times and 59.57 times, respectively. Read More | Source: The Hindu Business Line…
View More Emcure Pharma and Bansal Wire IPOs witness exceptional demand